Discover

CTKB
Cytek Biosciences, Inc.
4.58
2 x 3.29
2 x 5.68
bid
ask
+
0.15
3.39%
2 @ 04:00 PM
4.84 +0.26 (5.68%)
Ytd-9.31%
1y31.61%
4.42
day range
4.61
3.09
52 week range
6.18
Open4.45Prev Close4.43Low4.42High4.61Mkt Cap591.47M
Vol1.17MAvg Vol1.32MEPS-0.58P/EN/AForward P/E107.67
Beta1.32Short Ratio4.50Inst. Own59.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg4.19200-d Avg4.491yr Est8.40
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-052024-09-0.020.010.03150.00%
2024-08-062024-06-0.03N/AN/AN/A
2024-08-062024-06-0.03-0.08-0.05-166.67%
2024-05-082024-03-0.05-0.05N/AN/A
2024-05-082024-03-0.05N/AN/AN/A
2023-11-072023-090.02N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-11-11Piper SandlerUpgradeOverweightOverweight
2024-08-13Piper SandlerUpgradeOverweightOverweight
2024-05-13Piper SandlerUpgradeOverweightOverweight
2024-03-06Piper SandlerUpgradeOverweightOverweight
2024-02-29Goldman SachsUpgradeBuyBuy
2023-12-14Stephens & Co.UpgradeOverweight
Profile
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Insider Holder
DateNameRelationQuantityDescription
2024-11-17BARNETT VALERIEOfficer62.85KConversion of Exercise of derivative security
2024-11-17BUSQUE PHILIPPEOfficer12.87KConversion of Exercise of derivative security
2023-08-17GARLAND JONATHAN TODDOfficer8.76KConversion of Exercise of derivative security
2024-11-17HOLDER MICHAELDirector3.64KConversion of Exercise of derivative security
2024-03-10JEANMONOD PATRIKChief Financial Officer97.47KConversion of Exercise of derivative security
2024-11-17JIANG WENBINChief Executive Officer5.19MConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Blackrock Inc.18.49M119.46M14.36%
2024-09-29Vanguard Group Inc11.78M76.09M9.14%
2024-09-29Brown Capital Management, LLC9.49M61.33M7.37%
2024-09-29HHLR Advisors, LTD6.66M43.00M5.17%
2024-09-29State Street Corporation4.17M26.92M3.24%
2024-09-29Geode Capital Management, LLC2.67M17.24M2.07%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30iShares Core S&P Smallcap ETF6.82M44.05M5.29%
2024-09-29Vanguard Total Stock Market Index Fund3.47M22.44M2.70%
2024-09-29Brown Capital Management Small Company Fund3.46M22.38M2.69%
2024-10-30iShares Russell 2000 ETF3.12M20.17M2.42%
2024-09-29Vanguard Small-Cap Index Fund2.64M17.04M2.05%
2024-09-29Vanguard Extended Market Index Fund1.54M9.96M1.20%